Tiny Is Mighty

By KIM BELLARD I am a fanboy for AI; I don’t really understand the technical aspects, but I sure am excited about its potential. I’m also a sucker for a catchy phrase. So when I (belatedly) learned about TinyAI, I was hooked.   Now, as it turns out, TinyAI (also know as Tiny AI) has…

Read More

La comida chatarra es la nueva villana de Washington

Tus bocadillos podrían ser blanco del nuevo gobierno de Trump. Durante años, el gobierno federal ha evitado regular la comida chatarra, la comida rápida y los alimentos ultraprocesados. Ahora, las actitudes están cambiando. Algunos miembros del círculo íntimo del presidente Donald Trump se están preparando para luchar contra las “grandes empresas alimentarias”, es decir, las…

Read More

Summit Lung Cancer Drug Falls Short on Key Survival Goal in Global Study, Putting FDA Approval in Doubt

Despite achieving statistically signficant improvement in progression-free survival in North American and European patients, Summit’s drug ivonescimab fell short of the other Phase 3 goal measuring overall survival. It’s the first Phase 3 readout for an emerging class of bispecific antibodies that treat cancer by blocking two targets, PD-1 and VEGF. The post Summit Lung…

Read More

Prostate Cancer Management – We Need Better Options for Early-Stage Disease

We need to continue investing in research for early stage, localized prostate cancer, develop treatments that balance efficacy with quality-of-life considerations, ensure diverse representation in clinical trials, and listen to patients and incorporate their perspectives into treatment development and decision-making.  The post Prostate Cancer Management – We Need Better Options for Early-Stage Disease appeared first…

Read More